Min Ding

USPTO Granted Patents = 9 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 7(Granted Patents)

Location History:

Parsippany, NJ (US) (2017)
Irvington, NY (US) (2016 - 2020)
Tarrytown, NY (US) (2014 - 2021)

Company Filing History:

4 out of 26

The Medicines Company

patents

3 out of 328

Chiesi Farmaceutici S.p.a.

Melinta Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11058672 - Pharmaceutical compositions and methods for producing low impurity concentrations of the same (2021-07-13),

2. 10864249 - High purity oritavancin and method of producing same (2020-12-15),

3. 10328118 - High purity oritavancin and method of producing same (2019-06-25),

4. 10039780 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2018-08-07),

5. 9700575 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2017-07-11),

6. 9649352 - High purity oritavancin and method of producing same (2017-05-16),

7. 9439921 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2016-09-13),

8. 9295687 - Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same (2016-03-29),

9. 8754125 - Antimicrobial preservation of propofol emulsions (2014-06-17),

Title: Min Ding: Innovator in Pharmaceutical Compositions

Introduction

Min Ding is a notable inventor based in Irvington, NY (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he has made strides in developing innovative drug compositions and methods that enhance the purity and efficacy of pharmaceutical products.

Latest Patents

Among his latest patents, Min Ding has developed a pharmaceutical composition that includes clevidipine as an active ingredient. This composition is designed to maintain low impurity concentrations, specifically ensuring that the impurity H168/79 does not exceed 1.5%. Furthermore, the ratio of clevidipine to H168/79 is maintained at 60 to 1 or higher. Another significant patent involves high purity oritavancin, where he has disclosed methods for producing drug substance preparations with elevated purity levels. These preparations are crucial for creating effective pharmaceutical compositions and dosage forms.

Career Highlights

Throughout his career, Min Ding has worked with prominent companies in the pharmaceutical industry, including The Medicines Company and Chiesi Farmaceutici S.p.a. His work has been instrumental in advancing drug formulations that meet rigorous industry standards.

Collaborations

Min Ding has collaborated with several professionals in his field, including Adel Rafai Far and Rajeshwar Motheram. These collaborations have contributed to the successful development of his innovative pharmaceutical solutions.

Conclusion

Min Ding's contributions to pharmaceutical innovations highlight his expertise and commitment to improving drug formulations. His patents reflect a dedication to enhancing the purity and effectiveness of essential medications.

This text is generated by artificial intelligence and may not be accurate.